WASATCH ADVISORS LP

Holdings History for C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 4,852,741 shares
Security Ownership %: 6.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Wasatch Advisors LP ownership in C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

13 Nov 2025 - Wasatch Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,852,741 shares of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC). This represents 6.8% ownership of the company. In their previous filing dated 07 May 2025, WASATCH ADVISORS LP had reported owning 7,473,332 shares, indicating a decrease of +35%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Wasatch Advisors LP	6.8%	-34%	$10,773,085	4,852,741	-2,620,591	-35%	$2.22	13G/A	30 Sep 2025	13 Nov 2025, 17:33
WASATCH ADVISORS LP	10%		$11,508,931	7,473,332			$1.54	13G/A	30 Apr 2025	07 May 2025, 13:39

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	-0.01%	$8,298,793	4,344,918	-507,823	-10%	$1.91	Q4 2025
30 Sep 2025	0.06%	-0.03%	$10,773,085	4,852,741	-2,571,921	-35%	$2.22	Q3 2025
30 Jun 2025	0.06%	+0.01%	$10,617,267	7,424,662	+700,253	+10%	$1.43	Q2 2025
31 Mar 2025	0.06%	+0.01%	$10,759,054	6,724,409	+651,808		$1.60	Q1 2025
31 Dec 2024	0.11%	+0.01%	$21,861,364	6,072,601	+395,233	+7%	$3.60	Q4 2024
30 Sep 2024	0.16%	+0.02%	$32,360,998	5,677,368	+830,218	+17%	$5.70	Q3 2024
30 Jun 2024	0.12%	+0.01%	$22,393,833	4,847,150	+518,671	+12%	$4.62	Q2 2024
31 Mar 2024	0.18%	-0.12%	$35,363,673	4,328,479	-2,810,470	-39%	$8.17	Q1 2024
31 Dec 2023	0.22%	+0.03%	$40,335,062	7,138,949	+891,808	+14%	$5.65	Q4 2023
30 Sep 2023	0.07%	-0.01%	$11,619,682	6,247,141	-952,350	-13%	$1.86	Q3 2023
30 Jun 2023	0.12%	+0.02%	$19,798,600	7,199,491	+1,483,470	+26%	$2.75	Q2 2023
31 Mar 2023	0.11%	-0%	$17,948,306	5,716,021	-59,677	-1%	$3.14	Q1 2023
31 Dec 2022	0.23%	-0.01%	$34,076,618	5,775,698	-158,778	-2.7%	$5.90	Q4 2022
30 Sep 2022	0.36%	+0.02%	$52,045,000	5,934,476	+267,818	+4.7%	$8.77	Q3 2022
30 Jun 2022	0.27%	+0.2%	$42,727,000	5,666,658	+4,128,133	+268%	$7.54	Q2 2022
31 Mar 2022	0.18%	+0.03%	$37,325,000	1,538,525	+243,063	+19%	$24.26	Q1 2022
31 Dec 2021	0.17%	-0.01%	$41,714,000	1,295,462	-46,585	-3.5%	$32.20	Q4 2021
30 Sep 2021	0.24%	-0.01%	$59,963,000	1,342,047	-47,442	-3.4%	$44.68	Q3 2021
30 Jun 2021	0.21%	+0.05%	$52,578,000	1,389,489	+304,482	+28%	$37.84	Q2 2021
31 Mar 2021	0.18%	+0.18%	$40,135,000	1,085,007	+1,085,007	NEW	$36.99	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.